Zealand Pharma A/S
ZLDPF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.49B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $2.49 Billion |
|---|---|
| Enterprise Value | $-1,113,208,929.00 |
| Earnings per Share | $91.38 |
| Beta | 0.6 |
| Outstanding Shares | 70,348,419 |
Return
| Return on Equity | 15.20% |
|---|---|
| Return on Assets | 13.84% |
| Return on Invested Capital | 13.27% |
Valuation & Multiples
| P/E Ratio | 6.01 |
|---|---|
| PEG | -12.39 |
| Price to Sales | 0.54 |
| Price to Book Ratio | 0.14 |
| Enterprise Value to Revenue | 2.73 |
| Enterprise Value to EBIT | 5.19 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$0.14
Consensus analyst estimateRevenue Estimate
$692.12 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$-1.57
Consensus analyst estimateRevenue Estimate
$1.33 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Zealand Pharma A/S.
578 employees
CEO: Emmanuel Dulac
Zealand Pharma A/S is a Danish biotechnology firm dedicated to the identification, progression, and market introduction of peptide-based therapeutics. The company concentrates its efforts on treatments for gastrointestinal and metabolic ...